[1] JOSHI S, SINGH A R, WONG S S, et al. Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype[J]. PLoS One,2017,12(8):e0182851-e0182856. doi:  10.1371/journal.pone.0182851
[2] REN L M, LI R, CHEN L N, et al. Efficacy and safety of weekly leflunomide for the treatment of early rheumatoid arthritis: a randomized, multi-center study[J]. Int J Rheum Dis,2016,19(7):651-657. doi:  10.1111/1756-185X.12677
[3] BOCKHORN J, DALTON R, NWACHUKWU C, et al. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11[J]. Nat Commun,2013,4: 4(1):1393-1398.
[4] LI J, LU M J, JIN J, et al. MiR-449a suppresses tamoxifen resistance in human breast cancer cells by targeting ADAM22[J]. Cell Physiol Biochem,2018,50(1):136-149. doi:  10.1159/000493964
[5] HAN R H, JI X M, RONG R, et al. MiR-449a regulates autophagy to inhibit silica-induced pulmonary fibrosis through targeting Bcl2[J]. J Mol Med,2016,94(11):1267-1279. doi:  10.1007/s00109-016-1441-0
[6] TANG Y N, GENG Q, CHEN D, et al. Germline proliferation is regulated by somatic endocytic genes via JNK and BMP signaling in Drosophila[J]. Genetics,2017,206(1):189-197. doi:  10.1534/genetics.116.196535
[7] HUANG Y, MA S F, ESPINDOLA M S, et al. Microbes are associated with host innate immune response in idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Med,2017,196(2):208-219. doi:  10.1164/rccm.201607-1525OC
[8] DENG F, ZHANG P, FENG J, et al. Effect of leflunomideon inflammatory factors and immune function in rats with chronic glomerulonephritis[J]. J Sichuan Univ Med Sci Ed,2016,47(2):217-221.
[9] PATEL A, ZHANG S J, PARAMAHAMSA M, et al. Leflunomide induces pulmonary and hepatic CYP1A enzymes via aryl hydrocarbon receptor[J]. Drug Metab Dispos,2015,43(12):1966-1970. doi:  10.1124/dmd.115.066084
[10] SCOTT D L. Interstitial lung disease and disease modifying anti-rheumatic drugs[J]. Lancet,2004,363(9416):1239-1240.
[11] SAKAI F, NOMA S, KURIHARA Y, et al. Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features[J]. Mod Rheumatol,2005,15(3):173-179. doi:  10.3109/s10165-005-0387-9
[12] RYU C, SUN H X, GULATI M, et al. Extracellular mitochondrial DNA is generated by fibroblasts and predicts death in idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Med,2017,196(12):1571-1581. doi:  10.1164/rccm.201612-2480OC
[13] ISHIDA Y, KIMURA A, NOSAKA M, et al. Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration[J]. Sci Rep,2017,7(1):16833-16837. doi:  10.1038/s41598-017-17007-8
[14] LIANG L, HUIJUAN L, LIANJIANG D, et al. MiR-449a suppresses LDHA-mediated glycolysis to enhance the sensitivity of non-small cell lung cancer cells to ionizing radiation[J]. Oncol Res Feat Preclin Clin Cancer Therap,2017,26(4):547-556.
[15] WU D D, LIU J, CHEN J L, et al. MiR-449a suppresses tumor growth, migration, and invasion in non-small cell lung cancer by targeting a HMGB1-mediated NF-κB signaling pathway[J]. Oncol Res,2019,27(2):227-235. doi:  10.3727/096504018X15213089759999
[16] ZHANG J, GAO F D, NI T J, et al. Linc-POU3F3 is overexpressed in in-stent restenosis patients and induces VSMC phenotypic transformation via POU3F3/miR-449a/KLF4 signaling pathway[J]. Am J Transl Res,2019,11(7):4481-4490.
[17] SATO-MATSUBARA M, MATSUBARA T, DAIKOKU A, et al. Fibroblast growth factor 2(FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling[J]. J Biol Chem,2017,292(46):18961-18972. doi:  10.1074/jbc.M117.793794
[18] YANG Y L, YE Y J, QIU Q, et al. Triptolide inhibits the migration and invasion of rheumatoid fibroblast-like synoviocytes by blocking the activation of the JNK MAPK pathway[J]. Int Immunopharmacol,2016,41:8-16. doi:  10.1016/j.intimp.2016.10.005
[19] SHINGYOCHI Y, KANAZAWA S, TAJIMA S, et al. A low-level carbon dioxide laser promotes fibroblast proliferation and migration through activation of akt, ERK, and JNK[J]. PLoS One,2017,12(1):e0168937-e0168937. doi:  10.1371/journal.pone.0168937